Gilman Hill Asset Management, LLC / PFE
Gilman Hill Asset Management, LLC’s Pfizer Inc Position
Does Gilman Hill Asset Management, LLC own Pfizer Inc (PFE)? Yes — 428.2K shares worth $10M (+1.41% of its 13F portfolio) as of Q2 2026, up from 414.0K shares the prior filed quarter.
Position Value
$10M
Q2 2026
Shares
428.2K
% of Portfolio
+1.41%
Quarters Held
31
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 428.2K | $10M | +1.41% |
| Q1 2026 | 414.0K | $12M | +1.75% |
| Q4 2025 | 399.2K | $10M | +1.57% |
| Q3 2025 | 410.2K | $10M | +1.64% |
| Q2 2025 | 402.1K | $10M | +1.59% |
| Q1 2025 | 398.4K | $10M | +1.75% |
| Q4 2024 | 330.9K | $9M | +1.53% |
| Q3 2024 | 279.3K | $8M | +1.35% |
| Q2 2024 | 267.8K | $7M | +1.36% |
| Q1 2024 | 258.9K | $7M | +1.29% |
| Q4 2023 | 242.3K | $7M | +1.30% |
| Q3 2023 | 252.6K | $8M | +1.65% |
| Q2 2023 | 247.7K | $9M | +1.69% |
| Q1 2023 | 241.2K | $10M | +2.00% |
| Q4 2022 | 226.1K | $12M | +2.38% |
| Q3 2022 | 234.7K | $10M | +2.40% |
| Q2 2022 | 225.0K | $12M | +2.54% |
| Q1 2022 | 211.5K | $11M | +2.49% |
| Q4 2021 | 234.3K | $14M | +3.08% |
| Q3 2021 | 221.7K | $10M | +2.44% |
| Q2 2021 | 222.7K | $9M | +2.23% |
| Q1 2021 | 159.0K | $6M | +1.59% |
| Q4 2020 | 123.9K | $5M | +1.49% |
| Q3 2020 | 123.2K | $5M | +1.75% |
| Q2 2020 | 114.2K | $4M | +1.49% |
| Q1 2020 | 114.5K | $4M | +1.81% |
| Q4 2019 | 108.9K | $4M | +1.39% |
| Q3 2019 | 116.6K | $4M | +1.39% |
| Q2 2019 | 90.8K | $4M | +1.32% |
| Q1 2019 | 99.1K | $4M | +1.48% |
| Q4 2018 | 115.6K | $5M | +2.12% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gilman Hill Asset Management, LLC’s full portfolio or all institutional holders of PFE.